• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-145通过靶向黏附素抑制高级别浆液性卵巢癌的肿瘤生长和转移。

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.

作者信息

Dong Ruifen, Liu Xiaolin, Zhang Qing, Jiang Zhijun, Li Yingwei, Wei Yuyan, Li Yinuo, Yang Qifeng, Liu Jinsong, Wei Jian-Jun, Shao Changshun, Liu Zhaojian, Kong Beihua

机构信息

Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, Shandong, China.

Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.

出版信息

Oncotarget. 2014 Nov 15;5(21):10816-29. doi: 10.18632/oncotarget.2522.

DOI:10.18632/oncotarget.2522
PMID:25333261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279412/
Abstract

High-grade serous ovarian carcinoma (HGSOC), the most common and aggressive subtype of epithelial ovarian cancer, is characterized by TP53 mutations and genetic instability. Using miRNA profiling analysis, we found that miR-145, a p53 regulated miRNA, was frequently down-regulated in HGSOC. miR-145 down-regulation was further validated in a large cohort of HGSOCs by qPCR. Overexpression of miR-145 in ovarian cancer cells significantly suppressed proliferation, migration and invasion in vitro and inhibited tumor growth and metastasis in vivo. Metadherin (MTDH) was subsequently identified as a direct target of miR-145, and was found to be significantly up-regulated in HGSOC. Furthermore, overexpression of MTDH rescued the inhibitory effects of miR-145 in ovarian cancer cells. Finally, we found that high level of MTDH expression correlated with poor prognosis of HGSOC. Therefore, lack of suppression of MTDH by miR-145 when p53 is dysfunctional leads to increased tumor growth and metastasis of HGSOC. Our study established a new link between p53, miR-145 and MTDH in the regulation of tumor growth and metastasis in HGSOC.

摘要

高级别浆液性卵巢癌(HGSOC)是上皮性卵巢癌最常见且侵袭性最强的亚型,其特征为TP53突变和基因不稳定。通过miRNA谱分析,我们发现miR-145(一种p53调控的miRNA)在HGSOC中经常下调。通过qPCR在大量HGSOC队列中进一步验证了miR-145的下调。在卵巢癌细胞中过表达miR-145可显著抑制体外增殖、迁移和侵袭,并在体内抑制肿瘤生长和转移。随后鉴定出Metadherin(MTDH)是miR-145的直接靶点,并发现其在HGSOC中显著上调。此外,MTDH的过表达挽救了miR-145对卵巢癌细胞的抑制作用。最后,我们发现高水平的MTDH表达与HGSOC的不良预后相关。因此,当p53功能失调时,miR-145对MTDH的抑制缺失会导致HGSOC的肿瘤生长和转移增加。我们的研究在HGSOC的肿瘤生长和转移调控中建立了p53、miR-145和MTDH之间的新联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/d20a8eba130c/oncotarget-05-10816-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/ecc3a10601d2/oncotarget-05-10816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/5028c3975f58/oncotarget-05-10816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/063748aa8197/oncotarget-05-10816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/928ebb5408e9/oncotarget-05-10816-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/357650add0bf/oncotarget-05-10816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/034499936b0a/oncotarget-05-10816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/146f7d19613e/oncotarget-05-10816-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/d20a8eba130c/oncotarget-05-10816-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/ecc3a10601d2/oncotarget-05-10816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/5028c3975f58/oncotarget-05-10816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/063748aa8197/oncotarget-05-10816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/928ebb5408e9/oncotarget-05-10816-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/357650add0bf/oncotarget-05-10816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/034499936b0a/oncotarget-05-10816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/146f7d19613e/oncotarget-05-10816-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4b/4279412/d20a8eba130c/oncotarget-05-10816-g008.jpg

相似文献

1
miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.微小RNA-145通过靶向黏附素抑制高级别浆液性卵巢癌的肿瘤生长和转移。
Oncotarget. 2014 Nov 15;5(21):10816-29. doi: 10.18632/oncotarget.2522.
2
MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.MicroRNA-30a 通过靶向 metadherin 抑制乳腺癌的生长和转移。
Oncogene. 2014 Jun 12;33(24):3119-28. doi: 10.1038/onc.2013.286. Epub 2013 Jul 15.
3
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.综合分析确定了浆液性卵巢癌间充质亚型的主 miRNA 调控网络。
Cancer Cell. 2013 Feb 11;23(2):186-99. doi: 10.1016/j.ccr.2012.12.020.
4
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.微小RNA-30a-5p的过表达通过靶向MTDH/PTEN/AKT通路抑制肝癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.
5
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.卵巢癌及输卵管浆液性上皮内癌中MicroRNA-200通路的特征分析
BMC Cancer. 2017 Jun 17;17(1):422. doi: 10.1186/s12885-017-3417-z.
6
miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.miR-106a 通过抑制 Rb 肿瘤抑制因子 p130 来调节高级别浆液性卵巢癌中的细胞增殖和分化。
Mol Cancer Res. 2013 Nov;11(11):1314-25. doi: 10.1158/1541-7786.MCR-13-0131. Epub 2013 Sep 17.
7
miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.微小RNA-217通过靶向肝癌中的MTDH抑制细胞增殖、迁移和侵袭,促进细胞凋亡。
Oncol Rep. 2017 Mar;37(3):1772-1778. doi: 10.3892/or.2017.5401. Epub 2017 Jan 24.
8
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.多种直接和间接机制驱动雌激素诱导的高级别浆液性卵巢癌肿瘤生长。
Oncotarget. 2016 Feb 16;7(7):8155-71. doi: 10.18632/oncotarget.6943.
9
Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.小干扰 RNA 抑制结肠癌转移相关蛋白 1 对卵巢癌细胞 OVCAR-3 的影响。
J Exp Clin Cancer Res. 2011 Sep 16;30(1):83. doi: 10.1186/1756-9966-30-83.
10
MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.微小 RNA-625-3p 通过靶向 PTEN 改善高级别卵巢浆液性癌的增殖并涉及化疗耐药性。
J Ovarian Res. 2022 Jan 14;15(1):7. doi: 10.1186/s13048-021-00939-1.

引用本文的文献

1
The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p.通过使用MiR-145-5p靶向MYO6抑制前列腺癌上皮-间质转化
Int J Mol Sci. 2024 Apr 12;25(8):4301. doi: 10.3390/ijms25084301.
2
Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer.二甲双胍对卵巢癌中miRNA和lncRNA表达的调控机制
Pharmaceuticals (Basel). 2023 Oct 24;16(11):1515. doi: 10.3390/ph16111515.
3
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.

本文引用的文献

1
Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis.金属黏附素的基因消融抑制原发性前列腺癌的进展和转移。
Cancer Res. 2014 Sep 15;74(18):5336-47. doi: 10.1158/0008-5472.CAN-14-1349. Epub 2014 Jul 29.
2
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.MTDH-SND1 相互作用对于多种致癌基因和致癌物诱导的乳腺肿瘤中肿瘤起始细胞的扩增和活性至关重要。
Cancer Cell. 2014 Jul 14;26(1):92-105. doi: 10.1016/j.ccr.2014.04.027. Epub 2014 Jun 26.
3
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
卵巢癌中失调的miRNA簇:对个性化医疗的重要意义。
Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov.
4
Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.复发性和转移性卵巢癌中的循环非编码RNA
Cancer Drug Resist. 2019 Sep 19;2(3):399-418. doi: 10.20517/cdr.2019.51. eCollection 2019.
5
Angioregulatory microRNAs in breast cancer Molecular mechanistic basis and implications for therapeutic strategies.乳腺癌中的血管生成调节 microRNAs:分子机制基础及其对治疗策略的影响。
J Adv Res. 2021 Jun 26;37:235-253. doi: 10.1016/j.jare.2021.06.019. eCollection 2022 Mar.
6
Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis.间充质干细胞来源的外泌体作为转染 miR-145 进入乳腺癌细胞系的合适载体及其对转移的影响。
Biomed Res Int. 2021 Jun 29;2021:5516078. doi: 10.1155/2021/5516078. eCollection 2021.
7
lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.长链非编码 RNA CDKN2A-AS1 通过调节 SOSTDC1 介导的 BMP-SMAD 信号通路促进上皮性卵巢癌的发生和发展。
Cell Cycle. 2021 Jun;20(12):1147-1162. doi: 10.1080/15384101.2021.1924947. Epub 2021 Jun 10.
8
MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.miR-145 通过靶向钙黏蛋白-2 抑制前列腺癌细胞的迁移能力。
Mol Cell Biochem. 2021 Oct;476(10):3635-3646. doi: 10.1007/s11010-021-04188-0. Epub 2021 May 27.
9
Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer.非编码RNA作为上皮性卵巢癌肿瘤进展和转移扩散的生物标志物
Cancers (Basel). 2021 Apr 12;13(8):1839. doi: 10.3390/cancers13081839.
10
FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.FoxP3-miR-150-5p/3p 通过 IGF1R/IRS1 通路反馈环抑制卵巢肿瘤发生。
Cell Death Dis. 2021 Mar 15;12(3):275. doi: 10.1038/s41419-021-03554-6.
Brca;Tp53;Pten 模型中,输卵管分泌上皮的转化导致高级别浆液性卵巢癌。
Cancer Cell. 2013 Dec 9;24(6):751-65. doi: 10.1016/j.ccr.2013.10.013.
4
AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.AEG-1/MTDH/LYRIC:信号通路、下游基因、相互作用蛋白以及肿瘤血管生成的调控。
Adv Cancer Res. 2013;120:75-111. doi: 10.1016/B978-0-12-401676-7.00003-6.
5
The Role of microRNAs in the Tumorigenesis of Ovarian Cancer.microRNAs 在卵巢癌发生中的作用。
Front Oncol. 2013 Jun 13;3:153. doi: 10.3389/fonc.2013.00153. eCollection 2013.
6
Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.磷酸化热休克蛋白 27 激活 ATM 依赖性 p53 信号通路并介导 MCF-7 细胞对阿霉素诱导的细胞凋亡的抵抗。
Cell Signal. 2013 May;25(5):1176-85. doi: 10.1016/j.cellsig.2013.01.017. Epub 2013 Jan 26.
7
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.miR-141 调节 KEAP1 并调节卵巢癌细胞对顺铂的敏感性。
Oncogene. 2013 Sep 5;32(36):4284-93. doi: 10.1038/onc.2012.433. Epub 2012 Oct 8.
8
MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.miR-136 通过靶向 AEG-1 和 Bcl-2 促进神经胶质瘤细胞凋亡。
FEBS Lett. 2012 Oct 19;586(20):3608-12. doi: 10.1016/j.febslet.2012.08.003. Epub 2012 Aug 9.
9
MicroRNAs in the p53 network: micromanagement of tumour suppression.miRNAs 在 p53 网络中的作用:肿瘤抑制的微观管理。
Nat Rev Cancer. 2012 Sep;12(9):613-26. doi: 10.1038/nrc3318. Epub 2012 Aug 17.
10
Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.黏液性腺癌通过明确的遗传修饰从人输卵管上皮细胞发展而来。
Cell Cycle. 2012 Jun 1;11(11):2107-13. doi: 10.4161/cc.20544.